Bangladesh - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Bangladesh Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases was up 6.7% year on year. With 1,373 Cases in 2019, the country was ranked number 35 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. Bangladesh is overtaken by Mozambique, which was number 34 with 1,388 Cases and is followed by Kyrgyzstan at 1,359 Cases. India lead the ranking with 66,255 Cases in 2019, that is an increase of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 1,373.00 |
| 2018 | 1,228.00 |
| 2017 | 944.00 |
| 2016 | 969.00 |
| 2015 | 954.00 |
How does Bangladesh rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 34 |
#34
Mozambique
|
1,388 | 2019 | +19.9 % | +20.6 % | View data | |
| 35 |
#35
Bangladesh
|
1,373 | 2019 | +11.8 % | +6.7 % | View data | |
| 37 |
#37
Thailand
|
1,310 | 2019 | +4.9 % | +21.0 % | View data | |